Cancer Incidence Increased for People With Multiple Sclerosis
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Oct. 9, 2024 -- Cancer incidence is increased overall in people with multiple sclerosis (PwMS), with considerable differences depending on cancer type, age, and sex, according to a study published online Oct. 9 in Neurology.
Chloe Pierret, from Rennes University in France, and colleagues conducted a 10-year nationwide retrospective matched cohort study (2012 to 2021) using data from the national French administrative health care database to examine the time to first incident cancer among PwMS and a matched sample from the general population (matched in a 1:4 ratio). Participants had no history of cancer in the three years before inclusion.
The researchers found that cancer incidence was 799 per 100,000 person-years among 140,649 PwMS and 736 per 100,000 person-years among 562,596 matched controls. There was a small overall risk increase for PwMS (hazard ratio, 1.06), mainly among women (hazard ratio, 1.08). There was variation observed in risk by cancer type, with lower risk for prostate, breast, and colorectal cancer (hazard ratios, 0.80, 0.91, and 0.90, respectively), and higher risk for bladder, brain, and cervical cancer in PwMS (hazard ratios, 1.71, 1.68, and 1.24, respectively). PwMS younger than 55 years had higher cancer risk (hazard ratio, 1.20), but the risk decreased for those aged 65 years and older (hazard ratio, 0.89); this trend was consistent across cancer locations. Fewer PwMS than controls were screened (all programs), with a greater difference seen among those aged 65 years and older.
"Cancer incidence was increased in PwMS compared with the general population but varied greatly depending on cancer type, age, and sex," the authors write.
Several authors disclosed ties to the pharmaceutical industry.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted October 2024
Read this next
Autoimmune Diseases Linked to Digestive System Cancers
FRIDAY, Aug. 15, 2025 -- Autoimmune diseases are associated with certain digestive system cancers, according to a review published in the September issue of...
Subspecialization in Oncology Increasingly Utilized
MONDAY, Aug. 11, 2025 -- Subspecialization in oncology is increasing, but varies widely across cancer types and regions, according to a study published online Aug. 12 in the...
Broader Formulary Coverage Linked to Lower Odds of MS Relapse
FRIDAY, Aug. 8, 2025 -- Broader formulary coverage is associated with lower odds of multiple sclerosis (MS) relapse among Medicare beneficiaries, according to a study published...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.